Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Strategies involved in developing an effective vaccine for EBV-associated diseases.

× No keyword cloud information.

11 in total

1. Latent antigen vaccination in a model gammaherpesvirus infection.

Authors: E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal: J Virol Date: 2001-09 Impact factor: 5.103

2. T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics.

Authors: Joshua J Obar; Douglas C Donovan; Sarah G Crist; Ondine Silvia; James P Stewart; Edward J Usherwood
Journal: J Virol Date: 2004-10 Impact factor: 5.103

3. Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.

Authors: Janet Weslow-Schmidt; Fang Ye; Stephanie S Cush; Kathleen A Stuller; Marcia A Blackman; Emilio Flaño
Journal: J Virol Date: 2010-06-30 Impact factor: 5.103

4. Candidate vaccines for Epstein-Barr virus.

Authors: D J Moss; A Suhrbier; S L Elliott
Journal: BMJ Date: 1998-08-15

Review 5. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.

Authors: Abhik Saha; Erle S Robertson
Journal: Clin Cancer Res Date: 2011-03-03 Impact factor: 12.531

Review 6. Leishmaniasis: current status of vaccine development.

Authors: E Handman
Journal: Clin Microbiol Rev Date: 2001-04 Impact factor: 26.132

7. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.

Authors: L Liu; E J Usherwood; M A Blackman; D L Woodland
Journal: J Virol Date: 1999-12 Impact factor: 5.103

8. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway.

Authors: Jun Wan; Wei Zhang; Liming Wu; Ting Bai; Mingjie Zhang; Kwok-Wai Lo; Yiu-Loon Chui; Yan Cui; Qian Tao; Masahiro Yamamoto; Shizuo Akira; Zhenguo Wu
Journal: Mol Cell Biol Date: 2006-01 Impact factor: 4.272

9. Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.

Authors: Suzanne L Elliott; Andreas Suhrbier; John J Miles; Greg Lawrence; Stephanie J Pye; Thuy T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis J Moss; Mandvi Bharadwaj
Journal: J Virol Date: 2007-11-21 Impact factor: 5.103

10. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.

Authors: E J Usherwood; D J Roy; K Ward; S L Surman; B M Dutia; M A Blackman; J P Stewart; D L Woodland
Journal: J Exp Med Date: 2000-10-02 Impact factor: 14.307